The Specialist for Early Clinical Trials in Patients

ASCENT is a clinical research group whose core activities are Phase I/IIa, Proof of Concept and Bioequivalence studies in numerous patient populations, conducted in dedicated hospital based clinical pharmacology units in Russia. All clinics perform according to same SOP systems.

ASCENT offers Sponsors exceptional fast recruitment rates for patient populations in the following therapeutic areas: Cardiovascular, Metabolic, Respiratory, Neurology, Infectious diseases, Immune diseases, Gastro Intestinal, Urology, Kidney diseases, Liver diseases, Oncology.

Our staff has proudly contributed to more than 300 projects in Phase I to III over the last 10 years, most of them for the leading 20 pharmaceutical companies worldwide.

We’re also very experienced in complex exploratory protocols (intensive PK/PD) with long patient confinement.

WHY IS ASCENT SPECIAL?

ASCENT has the expertise to manage complex projects, for which challenging logistics, rare patient groups and experienced medical staff are required & supported by a modern Phase I infrastructure.